This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Eisenberg, M. J. Articles by Jamal, S. Search for Related Content PubMed PubMed Citation Articles by Eisenberg, M. J. Articles by Jamal, S.

Glycoprotein IIb/IIIa inhibition in the setting of acute ST-segment elevation myocardial infarction

^* Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada

View larger version (23K): [in a new window]   Figure 1 Percentage of patients with acute myocardial infarction achieving Thrombolysis In Myocardial Infarction (TIMI) 3 flow at 90 min after use of thrombolytic therapy alone versus thrombolytic therapy plus a glycoprotein (GP) IIb/IIIa inhibitor. Data adapted from references 3 to 5 and 8. For abbreviations see Abbreviations box.